Hyperhomocysteinemia and high doses of nilotinib favor cardiovascular events in chronic phase Chronic Myelogenous Leukemia patients

Journal article published in 2015 by G. Fossard, E. Blond, M. Balsat, S. Morisset, S. Giraudier, M. Escoffre-Barbe, H. Labussiere-Wallet, M. Heiblig

, A. Bert, M. Etienne, J. Drai, M. Sobh, I. Redonnet-Vernhet, J.-C. Lega, F.-X. Mahon and other authors.

This paper is made freely available by the publisher.

Full text: Download

Preprint: archiving forbidden

Postprint: archiving forbidden

Published version: archiving allowed

Upload

Policy details

Data provided by